Journal Content
Members of RegMedNet enjoy free access to selected articles from our partnered journals from the Taylor & Francis portfolio, including Regenerative Medicine [ISSN: 1746-0751, IF: 3 (2025), CiteScore: 3.9 (2025)], Immunotherapy [ISSN: 1750-7448, IF: 2.3 (2025), CiteScore: 4.2 (2025)] and Nanomedicine [ISSN: 1743-5889, IF: 4.6 (2025), CiteScore: 6.5 (2025)].
Our flagship journal partner, Regenerative Medicine, has been at the forefront of publishing the very best papers and reviews covering the entire regenerative medicine and advanced therapies sector for 20 years. The journal focuses on the entire spectrum of approaches to regenerative medicine, including small molecule drugs, biologics, biomaterials and tissue engineering, and cell and gene therapies – it’s all about regeneration and not a specific platform technology.
Sign up today for free access to selected articles from our partnered journals.